Rankings
▼
Calendar
MESO FY 2017 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena
MESO
Mesoblast Limited
$2B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-94.3% YoY
Gross Profit
-$10M
-400.2% margin
Operating Income
-$90M
-3733.1% margin
Net Income
-$77M
-3184.7% margin
EPS (Diluted)
$-1.40
Cash Flow
Operating Cash Flow
-$95M
Free Cash Flow
-$96M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$656M
Total Liabilities
$139M
Stockholders' Equity
$517M
Cash & Equivalents
$46M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$43M
-94.3%
Gross Profit
-$10M
$13M
-175.5%
Operating Income
-$90M
-$56M
-61.1%
Net Income
-$77M
-$4M
-1761.3%
← Q4 2016
All Quarters
Q1 2017 →